Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Norris

Showing results (431-440 of 531) with videos related to

Pageof 54
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 27, 2015
Folate pathway gene polymorphisms and risk of childhood brain tumors: results from an Australian case-control studyKathryn R Greenop, Rodney J Scott, John Attia, et al.
The Journal of Biological Chemistry|March 18, 2010
Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cellsAntonio Porro, Michelle Haber, Daniel Diolaiti, et al.
British Journal of Haematology|October 15, 2014
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemiaRosemary Sutton, Peter J Shaw, Nicola C Venn, et al.
Transplantation Proceedings|February 20, 2003
Durable and high rates of remission following chemotherapy in posttransplantation lymphoproliferative disorders after renal transplantationD Gill, H G Juffs, K A Herzig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2015
Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast CancerSuzanne E Wardell, Matthew J Ellis, Holly M Alley, et al.
Molecular Oncology|May 13, 2015
Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastomaBelamy B Cheung, Owen Tan, Jessica Koach, et al.
Cancer Research|July 12, 2020
Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC-Driven Cancer ProgressionJixuan Gao, MoonSun Jung, Chelsea Mayoh, et al.
Oncotarget|July 25, 2016
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4Chengyuan Xue, Denise M T Yu, Samuele Gherardi, et al.
International Journal of Cancer|July 21, 2019
Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemiaKlaartje Somers, Angelika Kosciolek, Angelika Bongers, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Sensitive and specific measurement of minimal residual disease in acute lymphoblastic leukemiaAlexander A Morley, Sue Latham, Michael J Brisco, et al.
Pageof 54

Showing results (431-440 of 531) with videos related to

Sort By:
Pageof 54
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 27, 2015
Folate pathway gene polymorphisms and risk of childhood brain tumors: results from an Australian case-control studyKathryn R Greenop, Rodney J Scott, John Attia, et al.
The Journal of Biological Chemistry|March 18, 2010
Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cellsAntonio Porro, Michelle Haber, Daniel Diolaiti, et al.
British Journal of Haematology|October 15, 2014
Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemiaRosemary Sutton, Peter J Shaw, Nicola C Venn, et al.
Transplantation Proceedings|February 20, 2003
Durable and high rates of remission following chemotherapy in posttransplantation lymphoproliferative disorders after renal transplantationD Gill, H G Juffs, K A Herzig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2015
Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast CancerSuzanne E Wardell, Matthew J Ellis, Holly M Alley, et al.
Molecular Oncology|May 13, 2015
Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastomaBelamy B Cheung, Owen Tan, Jessica Koach, et al.
Cancer Research|July 12, 2020
Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC-Driven Cancer ProgressionJixuan Gao, MoonSun Jung, Chelsea Mayoh, et al.
Oncotarget|July 25, 2016
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4Chengyuan Xue, Denise M T Yu, Samuele Gherardi, et al.
International Journal of Cancer|July 21, 2019
Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemiaKlaartje Somers, Angelika Kosciolek, Angelika Bongers, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Sensitive and specific measurement of minimal residual disease in acute lymphoblastic leukemiaAlexander A Morley, Sue Latham, Michael J Brisco, et al.
Pageof 54